[go: up one dir, main page]

IT1254858B - Metodo per la determinazione della frazione libera di sostanze presenti nei fluidi biologici. - Google Patents

Metodo per la determinazione della frazione libera di sostanze presenti nei fluidi biologici.

Info

Publication number
IT1254858B
IT1254858B ITMI920910A ITMI920910A IT1254858B IT 1254858 B IT1254858 B IT 1254858B IT MI920910 A ITMI920910 A IT MI920910A IT MI920910 A ITMI920910 A IT MI920910A IT 1254858 B IT1254858 B IT 1254858B
Authority
IT
Italy
Prior art keywords
analyte
free
concentration
biological fluids
determination
Prior art date
Application number
ITMI920910A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ITMI920910A priority Critical patent/IT1254858B/it
Publication of ITMI920910A0 publication Critical patent/ITMI920910A0/it
Priority to US07/997,735 priority patent/US5382530A/en
Priority to EP93105327A priority patent/EP0565949A2/en
Publication of ITMI920910A1 publication Critical patent/ITMI920910A1/it
Application granted granted Critical
Publication of IT1254858B publication Critical patent/IT1254858B/it

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

E' descritto un metodo per la determinazione diretta della concentrazione della frazione libera degli analiti presenti nei fluidi biologici in forma libera ed in forma legata ad uno o più leganti endogeni. Il metodo prevede l'impiego contemporaneo di almeno due specie di leganti esogeni. Il primo legante è in grado di sequestrare una quantità di analita proporzionale alla concentrazione di analita libero presente nel fluido biologico e di rilasciarla, dopo allontanamento dei leganti specifici endogeni, in seguito all'aggiunta di un opportuno agente dissociante. Il secondo è in grado di legare sia l'analita precedentemente rilasciato, sia una versione marcata dell'analita, anche in presenza dell'elemento dissociante. La misura della quantità di analita marcato che si lega al secondo legante esogeno, viene utilizzata per determinare la concentrazione nel fluido dell'analita libero.
ITMI920910A 1992-04-14 1992-04-14 Metodo per la determinazione della frazione libera di sostanze presenti nei fluidi biologici. IT1254858B (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITMI920910A IT1254858B (it) 1992-04-14 1992-04-14 Metodo per la determinazione della frazione libera di sostanze presenti nei fluidi biologici.
US07/997,735 US5382530A (en) 1992-04-14 1992-12-30 Method for the quantitative determination of a free form of substances present in biological fluids
EP93105327A EP0565949A2 (en) 1992-04-14 1993-03-31 Method for the quantitative determination of a free form of substances present in biological fluids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI920910A IT1254858B (it) 1992-04-14 1992-04-14 Metodo per la determinazione della frazione libera di sostanze presenti nei fluidi biologici.

Publications (3)

Publication Number Publication Date
ITMI920910A0 ITMI920910A0 (it) 1992-04-14
ITMI920910A1 ITMI920910A1 (it) 1993-10-14
IT1254858B true IT1254858B (it) 1995-10-11

Family

ID=11362940

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI920910A IT1254858B (it) 1992-04-14 1992-04-14 Metodo per la determinazione della frazione libera di sostanze presenti nei fluidi biologici.

Country Status (3)

Country Link
US (1) US5382530A (it)
EP (1) EP0565949A2 (it)
IT (1) IT1254858B (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998003876A1 (en) * 1996-07-18 1998-01-29 Behringwerke Aktiengesellschaft Reagents for assays for mycophenolic acid
US6284472B1 (en) 1998-10-05 2001-09-04 Dade Behring Inc. Method for extending the range of an immunoassay
GB0029729D0 (en) * 2000-12-06 2001-01-17 Ids Ltd Method for detection of vitamin D metabolites
WO2004059320A1 (ja) * 2002-12-26 2004-07-15 Nitto Boseki Co., Ltd. 免疫測定法およびそれに用いるキット
US20040132104A1 (en) * 2003-01-07 2004-07-08 Sackrison James L. Vitamin D assay
WO2008033073A1 (en) * 2006-09-14 2008-03-20 Ge Healthcare Bio-Sciences Ab A method of determining analyte concentration
CN113866429B (zh) * 2021-12-03 2022-02-22 南京岚轩生物科技有限公司 用于检测tt3和tt4含量的解离剂及其制备方法
CN114544831B (zh) * 2022-02-21 2024-05-10 成都翼泰生物科技有限公司 分离血液中游离甲状腺激素的方法及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3776698A (en) * 1972-01-24 1973-12-04 Nuclear Med Lab Test for thyroid hormone
NL7605447A (nl) * 1975-06-26 1976-12-28 Byk Mallinckrodt Chem Prod Radioimmunoproefmethode voor de bepaling van thyroxine.
IT1206354B (it) * 1977-03-10 1989-04-21 Lepetit Spa Corredo da usarsi per la determinazione degli ormoni liberi nei fluidi biologici
US4292296A (en) * 1978-09-12 1981-09-29 Baxter Travenol Laboratories, Inc. Diagnostic method
US4347058A (en) * 1980-09-15 1982-08-31 Beckman Instruments, Inc. Thyroid polarization fluoroimmunoassay
EP0089806B1 (en) * 1982-03-22 1989-06-28 AMERSHAM INTERNATIONAL plc Assay for the free portion of substances in biological fluids
JPS5923252A (ja) * 1982-07-30 1984-02-06 Fuji Photo Film Co Ltd チロキシンの蛍光測定もしくは比色による定量分析法
GB8317124D0 (en) * 1983-06-23 1983-07-27 Ekins R P Free ligand assay
GB8404843D0 (en) * 1984-02-24 1984-03-28 Amersham Int Plc Free analyte assay
US5036115A (en) * 1984-06-08 1991-07-30 Photoprotective Technologies, Inc. Optical lens system incorporating melanin as an absorbing pigment for protection against electromagnetic radiation
GB8800419D0 (en) * 1988-01-08 1988-02-10 Amersham Int Plc Method for measuring free fraction of ligands in biological fluids

Also Published As

Publication number Publication date
EP0565949A3 (it) 1994-01-05
EP0565949A2 (en) 1993-10-20
ITMI920910A0 (it) 1992-04-14
ITMI920910A1 (it) 1993-10-14
US5382530A (en) 1995-01-17

Similar Documents

Publication Publication Date Title
ES8407209A1 (es) Un metodo para determinar sitios insaturados de proteinas que se unen a tiroxina en una muestra que contiene proteinas que se unen a tiroxina
ES8101647A1 (es) Un metodo de determinacion de ligandos en muestras de ensayo
DK0734527T3 (da) Sensorindretning til sandwich-assay
ES2054617T3 (es) Nuevo metodo para la deteccion y/o determinacion cuantitativa de agentes ligantes especificos y sus correspondientes sustancias ligables.
DE69516007D1 (de) Verfahren zum nachweiss von antikörpern
MY134148A (en) Multi-layer reagent test strip
IT1254858B (it) Metodo per la determinazione della frazione libera di sostanze presenti nei fluidi biologici.
ATE172537T1 (de) Vorrichtung zur anreicherung von spurenkomponenten in einer flüssigkeit
ATE77149T1 (de) Verfahren und testkit zur bestimmung freier wirkstoffe in biologischen fluessigkeiten.
EP1353181A4 (en) BIOSENSOR AND METHOD FOR ANALYZING BLOOD CONSTITUENTS USING THE SAME
ZA914121B (en) Method of determining and/or dosing of hormones and antibodies for use in said method
NO943759D0 (no) Fremgangsmåte for bestemmelse av mengden av en ligand i et biologisk fluid, samt et analysesett for utförelse av en slik fremgangsmåte
ATE161332T1 (de) Vorrichtungen zur ausführung von ioneneinfangassays
ES8707342A1 (es) Un metodo de medida de la concentracion de un ligando libre en un fluido biologico
EP0441470A3 (en) Process for separating and measuring trace components
Rejnek et al. Radioimmunoelectrophoresis
DE60027176D1 (de) Nachweis von prostatakrebs durch bestimmen des verhältnisses von psa zu igf-1
DE69837758D1 (de) Verfahren und gerät zur bestimmung des gehalts einer komponente in einer fluiden probe
NO996464D0 (no) Test for karbohydratfri transferrin
ATE73233T1 (de) Verfahren zur bestimmung freier substanzen in biologischen fluessigkeiten.
ATE28938T1 (de) Verfahren und betreffende materialien zur messung des glukosegehaltes in koerperfluessigkeiten.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960429